|
LOC641298 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.2265999999902E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.07759999999646E-05 |
| Normal-vs-Stage2 |
1.80149999995383E-06 |
| Normal-vs-Stage3 |
1.81799999998677E-06 |
| Normal-vs-Stage4 |
2.08089999998995E-05 |
| Stage1-vs-Stage2 |
1.253600E-01 |
| Stage1-vs-Stage3 |
1.175620E-01 |
| Stage1-vs-Stage4 |
3.463600E-01 |
| Stage2-vs-Stage3 |
6.050800E-01 |
| Stage2-vs-Stage4 |
5.979200E-01 |
| Stage3-vs-Stage4 |
9.024600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.03920000000557E-05 |
| Normal-vs-AfricanAmerican |
3.206900E-04 |
| Normal-vs-Asian |
1.37739999961362E-07 |
| Caucasian-vs-AfricanAmerican |
5.252600E-01 |
| Caucasian-vs-Asian |
4.139600E-03 |
| AfricanAmerican-vs-Asian |
2.738600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.3897000002775E-07 |
| Normal-vs-Female |
2.02149999999346E-05 |
| Male-vs-Female |
7.985700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.799870E-04 |
| Normal-vs-Age(41-60Yrs) |
2.30619999996851E-06 |
| Normal-vs-Age(61-80Yrs) |
5.84449999951886E-07 |
| Normal-vs-Age(81-100Yrs) |
2.036100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.805700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.355920E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.072000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.805400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.449600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.941000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.656090E-02 |
| Classical-VS-Follicular |
9.288400E-02 |
| Classical-VS-Other |
4.990800E-01 |
| Classical-VS-Normal |
5.654300000002E-05 |
| Tall-VS-Follicular |
4.971000E-01 |
| Tall-VS-Other |
7.795400E-01 |
| Tall-VS-Normal |
5.71339999977383E-07 |
| Follicular-VS-Other |
9.202800E-01 |
| Follicular-VS-Normal |
2.97390000003617E-06 |
| Other-VS-Normal |
3.198000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78885999999601E-05 |
| Normal-vs-N1 |
3.955600E-04 |
| N0-vs-N1 |
5.325800E-01 |
|
|
